Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
NCT ID: NCT03884400
Last Updated: 2022-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2021-01-01
2026-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collection and Distribution of Biospecimens for Novel Research Uses
NCT03848962
A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host Microbe Scientific Study
NCT00765141
A Multi-Center Protocol for Obtaining and Storing Human Samples for Immediate or Future Microbial, Immune, or Host-Microbe Scientific Study
NCT00764023
Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick
NCT00339911
Compliant Analysis of Patient Samples and Data
NCT04364503
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Many of these biorepositories have protocols allowing for the collection of their samples but require an additional IRB or ethics review for the distribution of their samples.
This protocol establishes a method of such supply sites to allow their specimens to be distributed and used for research via iSpecimen's technology and network of research clients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects who have provided consent for specimen collection
Re-consent will not be required. This protocol allows distribution of the specimens following the terms agreed to by the subject in the original consent.
Specimens obtained from surgical, phlebotomy or other non-invasive procedure
Biospecimen Collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Specimens obtained from surgical, phlebotomy or other non-invasive procedure
Biospecimen Collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Specimens from biobanks that have collected materials and de-identified data under a waiver of consent
* Specimens from a biobank that meet the criteria for non human subject research under the common rule.
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
iSpecimen Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
iSpecimen
Lexington, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Website for specimen distribution
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISPC-180828-DISTRIBUTION
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.